ALC Alcon, Inc.

56.89-2.20 (-3.72%)
Close: November 20, 2019

57.000.11 (+0.19%)
After hours

Quote

Previous Close
$56.89
Day Range
$56.27-$57.84
52 Week Range
$53.78-$63.73
Volume
4,403,635
Avg Volume
982,116
Dividend TTM
-
Ex-Dividend Date
-

Valuation

Market Cap
$27.80B
Enterprise Value (EV)
$28.79B
PE Ratio
-
EV/EBITDA
20.71
Price/Sales
4.04
Price/Book
1.22
PEG Ratio
-

Financials

Revenue
$7.15B
Gross Profit
$3.19B
EBITDA
$1.39B
EPS, ttm
-
Profit Margin
-
Revenue/Employee
$350.96K
Next Earnings Date
2/26/2020 (98 days)
Debt to Equity
1%
Debt
$1.21B
Cash
$227.00M
Net Debt
$984.14M

Performance

Beta
-0.25
200 Day Moving Avg
$59.08
50 Day Moving Avg
$58.43
52 Week Change
1.81%
YTD Change
-1.91%
1 Month Change
1.01%
3 Month Change
-5.33%
6 Month Change
-0.87%
1 Year Change
1.81%
2 Year Change
1.81%
5 Year Change
1.81%

Share Count

Shares Outstanding
488.7M
Float
474.1M
Restricted Shares
14.6M
Restricted Shares, %
2.99%

Alcon, Inc. Company Details

Sector: Health Services

Industry: Hospital/Nursing Management

CEO: David J. Endicott

Website: http://www.alcon.com

Description: Alcon, Inc. engages in the development, manufacture, and marketing of market surgical equipment and devices, pharmaceutical eye drops, and consumer vision care products to treat eye diseases and disorders. It operates through Surgical and Vision Care segments. The Surgical segment offers implantable products, consumables and equipment for use in surgical procedures to address cataracts, vitreoretinal conditions, refractive errors, and glaucoma. The Vision Care segment comprises daily disposable, reusable and color-enhancing contact lenses, as well as portfolio of ocular health products, including over-the-counter products for dry eye, contact lens care, and ocular allergies, as well as ocular vitamins and redness relievers. The company was founded by Mr. Robert Alexander and Mr. William Conner on 1945 and is headquartered in Hünenberg, Switzerland.

Employees: 20,381